Physician profile
Igor Brichkov
NPI 1710162193
$8,370.45
in general payments reported to CMS, 2019-2025
10 companies · $2,731 in 2025
The $2,731 reported for 2025 was more than what 76% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,935 · 2022: $26.29 · 2024: $678 · 2025: $2,731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,306 · Food and Beverage: $638 · Consulting Fee: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,305.67 |
| Food and Beverage | $638.20 |
| Consulting Fee | $465.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $4,900.00 | 2019 | |
| Intuitive Surgical, INC. | $2,716.15 | 2025 | |
| Medtronic, INC. | $465.00 | 2024 | |
| On Target Laboratories, INC | $116.49 | 2024 | Cytalux |
| Ethicon US, LLC | $60.40 | 2024 | Echelon Endopath |
| Bolton Medical INC | $35.29 | 2019 | |
| Ethicon INC. | $26.29 | 2022 | |
| Adc Therapeutics America, INC. | $19.99 | 2024 | |
| Atricure, INC. | $16.34 | 2024 | |
| Fisher & Paykel Healthcare INC | $14.50 | 2025 | Fisher & Paykel Healthcare |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Igor Brichkov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.